District Court: Restrictions On Mifepristone Illegal But Will Remain In Effect Pending FDA Reconsideration - O'Neill : O'Neill

Health Affairs | November 3, 2025

Read the Publication

Issues

US Health Care Policy

Related Centers

Center for Health Policy and the Law

Latest publications See All

Journal Article

February 24, 2026

Advancing global health access through market shaping: Cases and learnings

Op-Ed

February 24, 2026

Why the Supreme Court’s Tariff Decision May Be Short-Lived

Op-Ed

February 20, 2026

Which way forward for Canada’s vaccine injury support program?